Testing NTX-2001 to reduce drinking in alcohol use disorder
Part of Mental health clinical trials.
This study tests whether a new medication called NTX-2001 can help people with alcohol use disorder drink less. Researchers will measure how the drug affects alcohol consumption and safety in adults aged 21–60.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have alcohol use disorder (diagnosed by a mental health professional using a standard assessment)
- You are between 21 and 60 years old and speak English
- Your weight is proportional to your height (BMI between 18–35)
- You have not been in alcohol treatment or seeking treatment in the past 6 months
- You do not have schizophrenia, psychosis, or other substance use disorders (except tobacco or mild cannabis use)
- If you can have children, you commit to using reliable birth control during the study and for 2 weeks after the last dose
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study tests a brief medication approach meant to reduce “problem drinking.” It may help people cut back or stop alcohol use by adjusting brain signaling related to drinking cravings and urges.
This study tests a new way to quickly screen medications for alcohol use disorder (AUD). You will have lab sessions where your drinking is monitored to see how different medicines affect your alcohol use.
This early-phase study looks at how the brain’s opioid receptor balance may be different in people with alcohol use disorder (AUD), using brain scans and blood testing. It may help researchers understand why some people respond differently to alcohol and related treatments.
This study tests whether a blood pressure medication called nimodipine can help reduce drinking in people with alcohol use disorder. If you are a heavy drinker and not seeking treatment right now, you may be able to join.
This trial tests if a blood pressure medication called nimodipine can help reduce alcohol drinking in people with moderate to severe alcohol use disorder. You'll take the medication or a placebo and participate in drinking sessions to see how it affects your alcohol intake.
This early-phase study looks at how alcohol affects impulsivity (tendency to act quickly) and people’s subjective experiences. You may be able to join if you drink regularly and meet the study safety rules.
Hear when a new Alcohol Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.